193 related articles for article (PubMed ID: 23300063)
1. Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
[TBL] [Abstract][Full Text] [Related]
2. Consumption of national health insurance medical resources by hepatocellular carcinoma patients treated using radiofrequency ablation therapy.
Kung CM; Mo LR; Yan YH
Asia Pac J Clin Oncol; 2012 Sep; 8(3):275-81. PubMed ID: 22897713
[TBL] [Abstract][Full Text] [Related]
3. The burden of illness associated with hepatocellular carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Shah S; Thompson D
J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
[TBL] [Abstract][Full Text] [Related]
4. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
[TBL] [Abstract][Full Text] [Related]
5. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
[TBL] [Abstract][Full Text] [Related]
6. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.
Wong WWL; Haines A; Bremner KE; Yao Z; Calzavara A; Mitsakakis N; Kwong JC; Sander B; Thein HH; Krahn MD
CMAJ Open; 2021; 9(1):E167-E174. PubMed ID: 33688024
[TBL] [Abstract][Full Text] [Related]
7. Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.
Thein HH; Qiao Y; Young SK; Zarin W; Yoshida EM; de Oliveira C; Earle CC
Curr Oncol; 2016 Jun; 23(3):e196-220. PubMed ID: 27330357
[TBL] [Abstract][Full Text] [Related]
8. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
[TBL] [Abstract][Full Text] [Related]
9. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
10. Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.
Skill NJ; Butler J; O'Brien DC; Kays JK; Kubal CA; Liangpunsakul S; Ninad N; Maluccio MA
Transplant Proc; 2019; 51(6):1907-1912. PubMed ID: 31399174
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
12. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
13. Medical care costs and survival associated with hepatocellular carcinoma among the elderly.
White LA; Menzin J; Korn JR; Friedman M; Lang K; Ray S
Clin Gastroenterol Hepatol; 2012 May; 10(5):547-54. PubMed ID: 22210536
[TBL] [Abstract][Full Text] [Related]
14. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
[TBL] [Abstract][Full Text] [Related]
15. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
Thein HH; Jembere N; Thavorn K; Chan KKW; Coyte PC; de Oliveira C; Hur C; Earle CC
BMC Cancer; 2018 Jun; 18(1):694. PubMed ID: 29945563
[TBL] [Abstract][Full Text] [Related]
16. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
[TBL] [Abstract][Full Text] [Related]
17. Phase-specific and lifetime costs of cancer care in Ontario, Canada.
de Oliveira C; Pataky R; Bremner KE; Rangrej J; Chan KK; Cheung WY; Hoch JS; Peacock S; Krahn MD
BMC Cancer; 2016 Oct; 16(1):809. PubMed ID: 27756310
[TBL] [Abstract][Full Text] [Related]
18. Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada.
de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
Value Health; 2017 Mar; 20(3):345-356. PubMed ID: 28292479
[TBL] [Abstract][Full Text] [Related]
19. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
